The US Food andSLOTDrug All you have to do is play the first few rounds that you haven't reached yet. With a small amount of money in the slot prize draw, go first to your turn calculated it This is the closest round to issue a prize. You can significantly increase your stake. You will receive the most prizes. As you wish, it's as easy as knowing and understanding. Your observations from the perspective of investment opportunity betting You will be able to make a lot of money as you want to bet Administration (FDA) on Monday (Jan. 31) approved the use of the COVID-19 vaccine. of moderna full For individuals aged 18 and over, it becomes the second coronavirus vaccine to be fully approved.
Moderna Vaccine Approved for Emergency Use in the U.S. It's been around since December 2020 and it's now being sold under the brand name Spikewax. After the previous COVID-19 vaccine of Pfizer/Biontech that uses the same technology approved for full use in the US For individuals aged 16 and over, since last year after the initial phase, it was also approved for emergency use.
According to the US Centers for Disease Control and Prevention (CDC), nearly 75 million people have received two doses of Moderna in the United States so far.
Janet Woodcock, MD, acting commissioner for the US Food and Drug Administration. stated in the statement that r0;People can rest assured that Spikewax meets the FDA's high standards for safety. production efficiency and quality prescribed for any vaccine as approved for use in the United States."
Moderna's Vaccines It is approved for use in more than 70 countries around the world. Among them included Canada and the European Union.
In January 2021, the company requested approval for the vaccine for youth aged 12-17, but the FDA has yet to respond.
Both Moderna and Pfizer/Biontech vaccines They are associated with myocardial infarction cases. especially young people While some studies suggest that the Moderna vaccine is more likely to cause side effects than the Pfizer/Biontech vaccine.
in October last year Moderna said the FDA is assessing the risk of myocardial infarction after vaccination. And the review has resulted in delays in the approval of vaccination among young people.
Portal
